Answers are grounded in this paper and cite their sources.
Background Retinoblastoma (RB) is the most common intraocular malignancy in children, but the role of PANoptosis, an integrated programmed cell death pathway involving apoptosis, pyroptosis, and necroptosis, remains unclear. Methods Bulk transcriptomic datasets from the GEO database were analyzed to identify PANoptosis-related differentially expressed genes (DEGs) in RB. Machine-learning algorithms were applied to develop a diagnostic signature. Functional enrichment, immune infiltration, drug–gene interaction, and ceRNA analyses were performed. Single-cell RNA sequencing was used to characterize the cellular distribution and biological functions of PANoptosis-related genes. Paired RB and adjacent retinal tissues from five patients were collected for RT-qPCR and western blot validation. Results Twenty-two PANoptosis-related DEGs were identified, and an exploratory five-gene signature consisting of BAX, CRADD, CD14, LY96, and TICAM1 showed promising apparent diagnostic discrimination in RB. External expression and ROC analyses provided additional support, although the small control cohorts limit performance inference. Single-cell analysis suggested different cellular distributions: BAX was relatively broadly detected in cone precursor-like tumor populations, whereas CD14 and LY96 were enriched in the microglia/macrophage compartment. Preliminary validation in five paired clinical specimens showed increased BAX, CD14, LY96, and TICAM1 mRNA expression and reduced CRADD expression; BAX protein abundance was also increased. Conclusions The five-gene PANoptosis-related signature represents an exploratory molecular finding in RB. Its clinical diagnostic value and mechanistic or therapeutic relevance require validation in larger independent cohorts and functional experiments.
No takes yet. Share an insight, caveat, or question.
Long et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: